Description:

GOG-0241 Surgical Reporting Form (C) NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E8EB-F792-E040-BB89AD433BF7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E8EB-F792-E040-BB89AD433BF7

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/9/15
  3. 7/3/15
Uploaded on:

July 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

GOG-0241 Surgical Reporting Form (C) NCT01081262

No Instruction available.

  1. StudyEvent: GOG-0241 Surgical Reporting Form (C)
    1. No Instruction available.
Header Module
Surgery assessment
Operative procedure performed (check all that apply)
Surgical approach
Stage
%
Residual gross tumor
cm
Microscopic disease only
Ascites
Cytology of peritoneal or ascitic fluids
Summary of operative findings
Exam
Proc
Comments

Similar models